Michelle Krogsgaard
Affiliations: | Basic Medical Science | New York University, New York, NY, United States |
Area:
Oncology, Immunology, Molecular BiologyGoogle:
"Michelle Krogsgaard"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Finnigan JP, Newman JH, Patskovsky Y, et al. (2024) Structural basis for self-discrimination by neoantigen-specific TCRs. Nature Communications. 15: 2140 |
| Patskovsky Y, Natarajan A, Patskovska L, et al. (2023) Molecular mechanism of phosphopeptide neoantigen immunogenicity. Nature Communications. 14: 3763 |
| Finnigan J, Newman J, Patskovsky Y, et al. (2023) Structural Basis for Self-Discrimination by Neoantigen-Specific TCRs. Research Square |
| Deng J, Thennavan A, Shah S, et al. (2020) Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment. Breast Cancer Research and Treatment |
| Yoshida T, Ichikawa J, Giuroiu I, et al. (2020) C reactive protein impairs adaptive immunity in immune cells of patients with melanoma. Journal For Immunotherapy of Cancer. 8 |
| Krogsgaard M, Moogk D, Li K, et al. (2019) Abstract PR08: Mechanisms of primary resistance to PD-1 checkpoint blockade Cancer Immunology Research. 7 |
| Deng J, Shah S, Thennavan A, et al. (2019) Abstract 4044: The immune phenotype in serial biopsies from metastatic TNBC undergoing chemo-immunotherapy Cancer Research |
| Moogk D, Wang L, Li K, et al. (2019) Abstract 3236: T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade Immunology |
| Natarajan A, Krogsgaard M. (2018) The myriad targets of a T cell. Nature Biotechnology. 36: 1152-1154 |
| Gowen MF, Giles KM, Simpson D, et al. (2018) Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. Journal of Translational Medicine. 16: 82 |